Although there was a consistent reduction in parasite burdens following anti-GITR mAb administration, this did not reach statistical significance, relative to control treated mice, in line with our previous findings[ 29 ].
1
—
—
Although there was a consistent reduction in parasite burdens following anti-GITR mAb administration, this did not reach statistical significance, relative to control treated mice, in line with our previous findings[ 29 ].